Screening HIV-infected women for cervical cancer in Thailand: Findings from a demonstration project

Sexually Transmitted Diseases

Volumn 34, Issue 2, 2007, Pages 104-107

  Sirivongrangson, Pachara ^a   Bollen, Liesbeth J M ^a   Chaovavanich, Achara ^b   Suksripanich, Orapin ^a   Virapat, Pongsri ^a   Tunthanathip, Preecha ^b   Ausavapipit, Jarurnsook ^b   Lokpichat, Somchai ^a   Siangphoe, Umaporn ^a   Jirarojwat, Naiyana ^a   Pobkeeree, Vallerut ^a   Supawitkul, Somsak ^a   Tappero, Jordan W ^a,c   Levine, William C ^a,c  

^a MINISTRY OF PUBLIC HEALTH   (Thailand)

^b Bamrasnaradura Infectious Disease Institute   (Thailand)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER SCREENING; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HEALTH CENTER; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PATIENT REFERRAL; PREVALENCE; SQUAMOUS CELL CARCINOMA; THAILAND; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; WART VIRUS;

ADULT; ALPHAPAPILLOMAVIRUS; FEMALE; HIV; HIV INFECTIONS; HUMANS; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; THAILAND; UTERINE CERVICAL NEOPLASMS;

EID: 33846404890     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.olq.0000222716.17186.9f     Document Type: Article

References (23)

1. Walboomers J, Jacobs M, Manos M, et al. Human papillomavirus is a necessary cause of invasive cervical cancer world-wide. J Pathol 1999; 189:12-19.
2. Ahdieh L, Klein R, Burk R, et al. Prevalence, incidence and type-specific persistence of human papillomavirus in human immunode-ficiency virus (HIV)-positive and HIV-negative women. J Infect Dis 2001; 184:690.
3. Levi JE, Kleter B, Quint WGV, et al. High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunodeficiency virus-infected women in Brazil. J Clin Microbiol 2002; 40:3341-3345.
4. Palefsky JM, Minkoff H, Kalish LA, et al. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high risk HIV-negative women. J Natl Cancer Inst 1999; 91:226-236.
5. Bollen LJM, Chuachoowong R, Kilmarx PH, et al. Human papillomavirus (HPV) detection among HIV-infected pregnant Thai women; implications for future HPV immunization. Sex Transm Dis 2006; 33:259-264.
6. Ellerbrock TV, Chiasson M, Bush T, et al. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA 2001; 283:1031-1037.
7. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002. MMWR Morb Mortal Wkly Rep 2002; 51:59.
8. Bureau of AIDS, TB and STIs, Thai Ministry of Public Health. National Guidelines for the Clinical Management of HIV Infection in Children and Adults, 8th ed, 2004. ISBN 974-297-298-2.
9. Srisongsom S, Lolekha R, Chunwimaleung S, et al. HIVQUAL-T: An innovative performance measurement tool for HIV care quality improvement in Thailand. International Conference on AIDS in Asia and the Pacific, 1-5 July, 2005; Abstract Sa B05-03. Kobe, Japan.
10. Chariyalertskak S, Sirisanthana T, Saengwonloey O, et al. Clinical presentation and risk behaviors of patients with acquired immunodeficiency syndrome in Thailand, 1994-1998: Regional variation and temporal trends. Clin Infect Dis 2001; 32:955-962.
11. Dal Maso L, Serraino D, Franceshchi S. Epidemiology of AIDS-related tumours in developed and developing countries. Eur J Cancer 2001; 37:1188-1201.
12. Maiman M, Frucher R, Guy L, et al. Cervical cancer as an AIDS-defining illness. Obstet Gynecol 1997; 89:76-80.
13. Minkoff H, Ahdieh L, Massad L, et al. The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women. AIDS 2001; 15:2157-2164.
14. Gates AE, Kaplan LD. AIDS malignancies in the era of highly active antiretroviral therapy. Oncology 2002; 16:657-665.
15. The 1991 Bethesda System for reporting cervical/vaginal cytologic diagnoses: Report of the 1991 Bethesda workshop. JAMA 1992; 267:1892.
16. Sirivongrangson P, Bollen LJM, Chaovavanich A, et al. Sexually transmitted infection services as a component of HIV care: Findings of a demonstration project among HIV-infected women in Thailand. J Acquir Immun Defic Syndr 2006; 41:671-674.
17. Thomas D, Ray NB, Kuypers J, et al. Human papillomaviruses and cervical cancer in Bangkok. III. The role of husbands and commercial sex workers. Am J Epidemiol 2001; 153:740-748.
18. Royal Thai College of Obstetricians and Gynaecologists (RTCOG)/JHPIEGO Corporation Cervical Cancer Prevention Group. Safety, acceptability, and feasibility of a single-visit approach to cervical-cancer prevention in rural Thailand: A demonstration project. Lancet 2003; 361:814-820.
19. Wright TC, Cox JT, Massad LS, et al. 2001 consensus guidelines for the management of women with cervical cancer abnormalities. JAMA 2002; 287:2120-2129.
20. Kirby TO, Allen ME, Alvarez RD, et al. High-risk human papillomavirus and cervical intraepithelial neoplasia at time of atypical squamous cells of undetermined significance cytologic results in a population with human immunodeficiency virus. J Low Genit Tract Dis 2004; 8:298-303.
21. Massad LS, Schneider MF, Watts DH, et al. HPV testing for triage of HIV-infected women with Papanicolaou smears read as atypical squamous cells of uncertain significance. J Womens Health 2004; 13:147-153.
22. Harris TG, Burk RD, Palefsky JM, et al. Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results. JAMA 2005; 293:1471-1476.
23. Wright TC, Schiffman M, Solomon D, et al. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol 2004; 103:304-309.